Skip to content
Screener

Arrowhead Research ARWR Compensation and benefits

Discontinued — last reported Q1 '18

Compensation and benefits at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$45.6M+53.6%

Segments

By segment

See full
Operating Segment$8.37M+2.9%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.

The source filing: Arrowhead Research’s 10-Q, filed February 9, 2018. Open the filing →

Filed
Feb 9, 2018, 4:11 PM EST
Fiscal quarter
Q1 FY2018
Calendar quarter
Q4 2017
Accession
0001564590-18-001768

FAQ

What does compensation and benefits mean?
Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.